87 related articles for article (PubMed ID: 21095575)
1. Cell-penetrant, nanomolar O-GlcNAcase inhibitors selective against lysosomal hexosaminidases.
Dorfmueller HC; Borodkin VS; Schimpl M; Zheng X; Kime R; Read KD; van Aalten DM
Chem Biol; 2010 Nov; 17(11):1250-5. PubMed ID: 21095575
[TBL] [Abstract][Full Text] [Related]
2. A mutant O-GlcNAcase as a probe to reveal global dynamics of protein O-GlcNAcylation during Drosophila embryonic development.
Mariappa D; Selvan N; Borodkin V; Alonso J; Ferenbach AT; Shepherd C; Navratilova IH; vanAalten DMF
Biochem J; 2015 Sep; 470(2):255-262. PubMed ID: 26348912
[TBL] [Abstract][Full Text] [Related]
3. Defining the structural origin of the substrate sequence independence of O-GlcNAcase using a combination of molecular docking and dynamics simulation.
Martin JC; Fadda E; Ito K; Woods RJ
Glycobiology; 2014 Jan; 24(1):85-96. PubMed ID: 24134879
[TBL] [Abstract][Full Text] [Related]
4. Understanding and exploiting the roles of O-GlcNAc in neurodegenerative diseases.
Pratt MR; Vocadlo DJ
J Biol Chem; 2023 Dec; 299(12):105411. PubMed ID: 37918804
[TBL] [Abstract][Full Text] [Related]
5. Target protein deglycosylation in living cells by a nanobody-fused split O-GlcNAcase.
Ge Y; Ramirez DH; Yang B; D'Souza AK; Aonbangkhen C; Wong S; Woo CM
Nat Chem Biol; 2021 May; 17(5):593-600. PubMed ID: 33686291
[TBL] [Abstract][Full Text] [Related]
6. Diaminocyclopentane - l-Lysine Adducts: Potent and selective inhibitors of human O-GlcNAcase.
Weber P; Bojarová P; Brouzdová J; Křen V; Kulik N; Stütz AE; Thonhofer M; Wrodnigg TM
Bioorg Chem; 2024 Jul; 148():107452. PubMed ID: 38763001
[TBL] [Abstract][Full Text] [Related]
7. Structural studies of a surface-entropy reduction mutant of O-GlcNAcase.
Males A; Davies GJ
Acta Crystallogr D Struct Biol; 2019 Jan; 75(Pt 1):70-78. PubMed ID: 30644846
[TBL] [Abstract][Full Text] [Related]
8. Highly functionalized diaminocyclopentanes: A new route to potent and selective inhibitors of human O-GlcNAcase.
Weber P; Mészáros Z; Bojarová P; Ebner M; Fischer R; Křen V; Kulik N; Müller P; Vlachová M; Slámová K; Stütz AE; Thonhofer M; Torvisco A; Wrodnigg TM; Wolfsgruber A
Bioorg Chem; 2023 Nov; 140():106819. PubMed ID: 37666109
[TBL] [Abstract][Full Text] [Related]
9. Advances in chemical probing of protein
Saha A; Bello D; Fernández-Tejada A
Chem Soc Rev; 2021 Sep; 50(18):10451-10485. PubMed ID: 34338261
[TBL] [Abstract][Full Text] [Related]
10. Molecular Interrogation to Crack the Case of O-GlcNAc.
Estevez A; Zhu D; Blankenship C; Jiang J
Chemistry; 2020 Sep; 26(53):12086-12100. PubMed ID: 32207184
[TBL] [Abstract][Full Text] [Related]
11. Loss of CRMP2 O-GlcNAcylation leads to reduced novel object recognition performance in mice.
Muha V; Williamson R; Hills R; McNeilly AD; McWilliams TG; Alonso J; Schimpl M; Leney AC; Heck AJR; Sutherland C; Read KD; McCrimmon RJ; Brooks SP; van Aalten DMF
Open Biol; 2019 Nov; 9(11):190192. PubMed ID: 31771416
[TBL] [Abstract][Full Text] [Related]
12. Genetic recoding to dissect the roles of site-specific protein O-GlcNAcylation.
Gorelik A; Bartual SG; Borodkin VS; Varghese J; Ferenbach AT; van Aalten DMF
Nat Struct Mol Biol; 2019 Nov; 26(11):1071-1077. PubMed ID: 31695185
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycemia-Induced Aberrant Cell Proliferation; A Metabolic Challenge Mediated by Protein O-GlcNAc Modification.
Nagy T; Fisi V; Frank D; Kátai E; Nagy Z; Miseta A
Cells; 2019 Aug; 8(9):. PubMed ID: 31466420
[TBL] [Abstract][Full Text] [Related]
14. Computational Studies on the Potency and Selectivity of PUGNAc Derivatives Against GH3, GH20, and GH84 β-N-acetyl-D-hexosaminidases.
Dong L; Shen S; Xu Y; Wang L; Feng R; Zhang J; Lu H
Front Chem; 2019; 7():235. PubMed ID: 31111026
[TBL] [Abstract][Full Text] [Related]
15. Analysis of transition state mimicry by tight binding aminothiazoline inhibitors provides insight into catalysis by human
Cekic N; Heinonen JE; Stubbs KA; Roth C; He Y; Bennet AJ; McEachern EJ; Davies GJ; Vocadlo DJ
Chem Sci; 2016 Jun; 7(6):3742-3750. PubMed ID: 29997861
[TBL] [Abstract][Full Text] [Related]
16. O-GlcNAcase Fragment Discovery with Fluorescence Polarimetry.
Borodkin VS; Rafie K; Selvan N; Aristotelous T; Navratilova I; Ferenbach AT; van Aalten DMF
ACS Chem Biol; 2018 May; 13(5):1353-1360. PubMed ID: 29641181
[TBL] [Abstract][Full Text] [Related]
17. Potent GH20 N-Acetyl-β-d-hexosaminidase Inhibitors: N-Substituted 3-acetamido-4-amino-5-hydroxymethyl-cyclopentanediols.
Weber P; Nasseri SA; Pabst BM; Torvisco A; Müller P; Paschke E; Tschernutter M; Windischhofer W; Withers SG; Wrodnigg TM; Stütz AE
Molecules; 2018 Mar; 23(3):. PubMed ID: 29558439
[TBL] [Abstract][Full Text] [Related]
18. Deciphering the Functions of Protein O-GlcNAcylation with Chemistry.
Worth M; Li H; Jiang J
ACS Chem Biol; 2017 Feb; 12(2):326-335. PubMed ID: 28055183
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of Human Nucleocytoplasmic Hexosaminidase D.
Alteen MG; Oehler V; Nemčovičová I; Wilson IB; Vocadlo DJ; Gloster TM
Biochemistry; 2016 May; 55(19):2735-47. PubMed ID: 27149221
[TBL] [Abstract][Full Text] [Related]
20. Glucose and glutamine fuel protein O-GlcNAcylation to control T cell self-renewal and malignancy.
Swamy M; Pathak S; Grzes KM; Damerow S; Sinclair LV; van Aalten DM; Cantrell DA
Nat Immunol; 2016 Jun; 17(6):712-20. PubMed ID: 27111141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
